Effects of Eldecalcitol and Raloxifene on the suppression of new vertebral fracture with osteoporosis in perimenopausal women or ovariectomy patients: Randomized controlled trial
Not Applicable
Recruiting
- Conditions
- osteoporosis in perimenopausal women or ovariectomy patients
- Registration Number
- JPRN-UMIN000009378
- Lead Sponsor
- Tokyo Women's Medical University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 360
Inclusion Criteria
Not provided
Exclusion Criteria
1,If the disease has progressed apparently. 2,If the patient is no longer any reason to visit. 3,Others, If the patient wishes to have the discontinuation of treatment with this protocol. or If the doctor determines that difficult to continue treatment with this protocol.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary end point is incident of new vertebral fractures.
- Secondary Outcome Measures
Name Time Method The secondary end points included the changes in bone mineral density of lumbar spine (L2-L4 BMD) and changes in bone turnover markers (tartrate resistant acid phosphatase-5b (TRACP5b), bone-alkaline phosphatase (BAP)).